newsfilter
← Latest News
PR Newswire·

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

NEW YORK, May 18, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at